Stem Cells and Therapy: A Themed Honorary Issue to Prof. Luc Douay

Dear Colleagues,

This Special Issue of Hemato will contain manuscripts from leading scientists throughout the world to honor Prof. Luc Douay for his outstanding contributions in the field of hematopoietic stem cells and its application to cell therapy. Prof. Luc Douay has largely contributed in the concept of cultured red blood cells (cRBC) generated in vitro from stem cells for transfusion purposes and first described all the major steps. In recent decades, there has been an explosion of interest in stem cell in both basic and translational research, which has now penetrated all areas of modern biology, offering new perspectives on developmental disorders, including cancer. In this Special Issue, we aim to highlight some of the most important and topical issues—including recent advances, controversies, and challenges in stem cell research, and of course their clinical implications. New tools, such as organoid culture and single cell technologies; novel methods and new protocols improving cells for regenerative purposes and studying stem cell aging and cancer; and new therapies based on stem cell transplantation or endogenous stem cells will be presented. Each contribution should reflect the spirit and the main objective that has guided Prof. Luc Douay, the successful transfer of the innovative concept from Bench to Bed.

Dr. Michèle Sabbah
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Hemato is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.